10/05/2015 | Sponsored by Santen Pharmaceuticals
Preserved glaucoma product use increases the probability that future glaucoma surgery will fail. Let’s examine the literature…
10/05/2015
Though highly successful, retinoblastoma radio- and chemotherapy increases the risk of secondary cancer. Is there an alternative?
10/05/2015 | Michael Schubert
New neuroscience reveals that the synaptic connections between the retinal ganglion cells and the visual cortex are not as simple as first thought
Two research teams have developed very different ways of tackling retinitis pigmentosa, but both hold great promise
Object motion detector cell function relies on a unique interneuron and a special ‘sidekick’ recognition protein
In patients with keratoconus, CXL halts progression up to seven years on
Peripheral retinal lesions may predict diabetic patients’ risk of disease progression – and ultrawide field imaging could enable a better and earlier early diagnosis
10/05/2015 | Mark Hillen
Why is public awareness of dry eye so disturbingly low, and what can be done to change this?
09/29/2015
The feedback and reactions to the first public presentation of Heidelberg Engineering’s new Cataract and Refractive Imaging Platform* at the ESCRS in Barcelona were extremely positive. Many leading ophthalmologists visited Heidelberg Engineering’s booth for a hands-on preview of the swept-source OCT Cataract and Refractive Imaging Platform and had the chance to experience its versatility. Have a look at this Eyewire TV to find out more.
09/14/2015
For doctors and other operators to get familiar with the Widefield Imaging Module, the Heidelberg Engineering Academy has recently launched an interactive video tutorial.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: